A humanin derivative reduces amyloid beta accumulation and ameliorates memory deficit in triple transgenic mice. by Takako Niikura, Elkhansa Sidahmed, Chiho Hirata-Fukae, Paul S Aisen, Yasuji Matsuoka

Get full text

Using the Guttman scale to define and estimate measurement error in items over time: the case of cognitive decline and the meaning of "points lost". by Rochelle E Tractenberg, Futoshi Yumoto, Paul S Aisen, Jeffrey A Kaye, Robert J Mislevy

Get full text

Bayesian latent time joint mixed‐effects model of progression in the Alzheimer's Disease Neuroimaging Initiative by Dan Li, Samuel Iddi, Wesley K. Thompson, Michael S. Rafii, Paul S. Aisen, Michael C. Donohue, Alzheimer's Disease Neuroimaging Initiative

Get full text

Predicting the course of Alzheimer’s progression by Samuel Iddi, Dan Li, Paul S. Aisen, Michael S. Rafii, Wesley K. Thompson, Michael C. Donohue, for the Alzheimer’s Disease Neuroimaging Initiative

Get full text

Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease by Sheila Seleri Assunção, Reisa A. Sperling, Craig Ritchie, Diana R. Kerwin, Paul S. Aisen, Claire Lansdall, Alireza Atri, Jeffrey Cummings

Get full text

The Down Syndrome Biomarker Initiative (DSBI) Pilot: Proof of Concept for Deep Phenotyping of Alzheimer’s Disease Biomarkers in Down Syndrome by Michael eRafii, Hannah eWishnek, James eBrewer, Michael eDonohue, Seth eNess, William eMobley, Paul eAisen, Robert eRissman

Get full text

Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial‐Ready Cohort study by Kenichiro Sato, Ryoko Ihara, Kazushi Suzuki, Yoshiki Niimi, Tatsushi Toda, Gustavo Jimenez‐Maggiora, Oliver Langford, Michael C. Donohue, Rema Raman, Paul S. Aisen, Reisa A. Sperling, Atsushi Iwata, Takeshi Iwatsubo

Get full text

Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease by Michael F. Egan, Yuki Mukai, Tiffini Voss, James Kost, Julie Stone, Christine Furtek, Erin Mahoney, Jeffrey L. Cummings, Pierre N. Tariot, Paul S. Aisen, Bruno Vellas, Christopher Lines, David Michelson

Get full text

Feasibility study for detection of retinal amyloid in clinical trials: The Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial by Jennifer Ngolab, Michael Donohue, Alison Belsha, Jennifer Salazar, Paula Cohen, Sandhya Jaiswal, Veasna Tan, Devon Gessert, Shaina Korouri, Neelum T. Aggarwal, Jessica Alber, Ken Johnson, Gregory Jicha, Christopher vanDyck, James Lah, Stephen Salloway, Reisa A. Sperling, Paul S. Aisen, Michael S. Rafii, Robert A. Rissman

Get full text

Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease by Kwangsik Nho, Sungeun Kim, Emrin Horgusluoglu, Shannon L. Risacher, Li Shen, Dokyoon Kim, Seunggeun Lee, Tatiana Foroud, Leslie M. Shaw, John Q. Trojanowski, Paul S. Aisen, Ronald C. Petersen, Clifford R. Jack, Michael W. Weiner, Robert C. Green, Arthur W. Toga, Andrew J. Saykin, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Get full text

Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study by Gad A. Marshall, Sietske A. M. Sikkes, Rebecca E. Amariglio, Jennifer R. Gatchel, Dorene M. Rentz, Keith A. Johnson, Oliver Langford, Chung‐Kai Sun, Michael C. Donohue, Rema Raman, Paul S. Aisen, Reisa A. Sperling, Douglas R. Galasko, Full listing of A4 Study team and site personnel available at A4STUDY.org

Get full text

Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel. by Sungeun Kim, Shanker Swaminathan, Mark Inlow, Shannon L Risacher, Kwangsik Nho, Li Shen, Tatiana M Foroud, Ronald C Petersen, Paul S Aisen, Holly Soares, Jon B Toledo, Leslie M Shaw, John Q Trojanowski, Michael W Weiner, Brenna C McDonald, Martin R Farlow, Bernardino Ghetti, Andrew J Saykin, Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Get full text

The Role of Apolipoprotein E (APOE) Genotype in Early Mild Cognitive Impairment (E-MCI) by Shannon L Risacher, Sungeun eKim, Sungeun eKim, Li eShen, Li eShen, Kwangsik eNho, Tatiana eForoud, Robert C Green, Ronald C Petersen, Clifford R Jack, Paul S Aisen, Robert A Koeppe, William J Jagust, Leslie M Shaw, John Q Trojanowski, Michael W Weiner, Michael W Weiner, Andrew J Saykin

Get full text